Return on Equity (ROE): Quest Diagnostics's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 3.24%, the company may encounter ...

Quest Diagnostics Inc. closed 1.22% short of its 52-week high of $178.87, which the company achieved on March 10th.

SECAUCUS, N.J. (AP) — SECAUCUS, N.J. (AP) — Quest Diagnostics Inc. (DGX) on Tuesday reported first-quarter earnings of $220 million. On a per-share basis, the Secaucus, New Jersey-based company said ...

James Davis; Executive Chairman of the Board, President, Chief Executive Officer; Quest Diagnostics Inc Sam Samad; Chief Financial Officer, Executive Vice President; Quest Diagnostics Inc Welcome ...

Quest Diagnostics (DGX) excels in diagnostics services but trades at a high valuation. Valuation analysis shows DGX trading ...

Quest Diagnostics Inc (DGX) reports a robust 12% revenue increase and reaffirms its positive financial outlook for 2025, driven by strategic advancements and partnerships. Demand for diagnostic ...

Quest Diagnostics reported its Q1 2025 earnings, surpassing market expectations with an adjusted earnings per share (EPS) of $2.21, compared to a forecasted $2.16. Revenue reached 2.65 billion ...

Quest Diagnostics Trading Down 0.4 % NYSE DGX opened at $163.75 on Friday. The company has a quick ratio of 1.02, a current ratio of 1.10 and a debt-to-equity ratio of 0.82. The firm has a 50 day ...

Try Now>> See the top stocks recommended by analysts >> Read More on DGX: Disclaimer & Disclosure Report an Issue Quest Diagnostics NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

Quest Diagnostics posted first-quarter revenue growth of 12%, and tight control over expenses drove earnings growth up 13% year over year. Why it matters: Though inclement weather damped volume ...

James Davis; Executive Chairman of the Board, President, Chief Executive Officer; Quest Diagnostics Inc Sam Samad; Chief Financial Officer, Executive Vice President; Quest Diagnostics Inc Welcome to ...

Quest Diagnostics Inc.’s stock rose 3% early Tuesday, after the company posted better-than-expected first-quarter earnings and backed its full-year guidance, but acknowledged the early part of ...